Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2021-04-29 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
NEXT DAY DISCLOSURE RETURNS
Transaction in Own Shares Classification · 95% confidence The document is a Next Day Disclosure Return for a GEM listed issuer, Sinopharm Tech Holdings Limited, detailing changes in issued share capital and share buybacks. It includes specific data on share issues, repurchases, and confirmations related to compliance with GEM Listing Rules. The content focuses on reporting changes in share capital and share repurchases, which aligns with announcements regarding share capital changes or share buybacks. It is not a full financial report, earnings release, or management discussion. The document is regulatory in nature, providing disclosure of capital changes as required by stock exchange rules. Therefore, it fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares and related capital changes.
2021-04-29 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2021
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' and is addressed to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized share capital, issued share capital, share options, warrants, convertibles, and other share-related transactions for the month ended 31/03/2021. The content focuses on share capital changes, share options, and confirmations related to securities issuance. There are no financial statements, earnings data, management discussion, or audit information. The document is a regulatory filing reporting share capital movements and related confirmations to the stock exchange, consistent with a regulatory compliance announcement rather than a full financial report or announcement of voting results. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-04-09 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a delay in the despatch of a circular related to a discloseable and connected transaction and continuing connected transaction. It references previous announcements and states that the circular, which contains details of agreements and a notice convening an Extraordinary General Meeting (EGM), will be delayed. The document is short (3303 characters) and serves to inform shareholders about the delay in sending the circular rather than providing the circular itself or detailed financial data. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement providing compliance information and updates, not the actual circular or a financial report.
2021-03-31 English
POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 22 MARCH 2021
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the poll results from an Extraordinary General Meeting (EGM) held on 22 March 2021. It details the voting outcome on a specific resolution, including vote counts and percentages, and confirms the resolution was passed. The document references the EGM notice and circular but does not contain any financial statements or detailed financial analysis. It is a formal announcement of voting results rather than the meeting materials themselves or a full report. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4609 characters, which is consistent with a detailed announcement but not a full report. Hence, the classification is DVA with high confidence.
2021-03-22 English
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO (1) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF 25% EQUITY INTEREST IN THE TARGET COMPANY INVOLVING THE ISSUE OF CONSIDERATION SHA
Capital/Financing Update Classification · 95% confidence The document is titled as a 'Supplemental Announcement' related to a discloseable and connected transaction involving acquisition and continuing connected transaction. It references a previous announcement dated 18 February 2021 and provides additional information about the Chinese name of a person involved. The document is relatively short (3349 characters) and serves to supplement or clarify information in a prior announcement rather than presenting full financial data or detailed transaction terms. It is an announcement related to capital transactions but does not contain comprehensive financial statements or detailed financing updates. Given the nature of the content—an update or supplement to a prior announcement about a transaction involving issuance of shares under a specific mandate—it fits best under Capital/Financing Update (CAP). It is not a full report, earnings release, or regulatory filing, but a supplemental announcement about a capital transaction.
2021-03-17 English
FORM OF PROXY
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use by shareholders at an extraordinary general meeting (EGM) of Sinopharm Tech Holdings Limited. It includes instructions for appointing a proxy to vote on resolutions at the meeting, details about the meeting date and location, and notes on how to complete the form. There is no financial data, management discussion, or report content. This document is a solicitation for shareholder votes rather than a report or announcement of results. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length is just over 5,000 characters but the content clearly matches a proxy form, not a report or announcement.
2021-03-04 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.